linkedin post 2013-02-12 06:27:49
WESTERN PHARMA's R&D MODEL is clearly broken, so just ranking highly for throwing capital at a research organization is not impressive. Better to see that capital divided into numerous outsourced financings with small innovative companies, who are infinitely mire productive and imaginative. http://m.timesofindia.com/business/india-business/Indian-companies-top-global-charts-for-investment-in-RD/articleshow/18099909.cms View in LinkedIn
linkedin post 2013-02-12 06:18:54
PATIENT OUTCOMES are becoming an important metric for new drugs, and long overdue. Gatekeeping of a successful medicine has shifted in recent years from the FDA to payers, and pharmacoeconomics, as the UK's NICE committee has recently demonstrated in exclusion decisions for expensive drugs. http://lnkd.in/dejJgi View in LinkedIn
linkedin post 2013-02-12 06:07:39
MANAGEMENT, MANAGEMENT, MANAGEMENT, is a key to startups, as true as location is in real estate transactions. One trait I have observed in several talented Founder-CEOs is a curious loyalty and hesitancy to fire a bad apple even when it is clearly the case. In all instances, after-the-fact relief was experienced, along with the realization it was very long overdue. Act decisively, be fair and consistent, and this includes acknowledging YOU made the bad hire. People will understand. http://lnkd.in/tGUwYJ View in LinkedIn
linkedin post 2013-02-15 07:21:36
MEDICAL DEVICES ARE EXPENSIVE TO DEVELOP, so read this summary of ways to avoid big expenses. As usual, the FDA is one of the cost hurdles. http://lnkd.in/zmG-pf View in LinkedIn
linkedin post 2013-02-11 08:23:18
WITHOUT FEAR AND HUNGER, FOUNDERS CANNOT ATTEMPT THE IMPOSSIBLE. These are vital ingredients for sharpening and focusing intentionality. Always remember that those working for the 800 lb gorilla (your worst competitor) are comfortable, secure, and not ever going to stretch and attempt the impossible. A big competitor is not as bad as it looks. View in LinkedIn
linkedin post 2013-02-15 07:06:48
DNA SEQUENCING FOR 900 USD? We have been talking about this possibility for years. Harvard's George Church is at the heart of another major advance. This GAME CHANGER is going to have enormous consequences. DNA sequences are going to be at the dining room table, under furious debate by ethicists, and at the forefront of disease gene mapping. The Genie is out of the bottle now, and the only question is how we wisely use this knowledge to create healthier societies, and at last enter the practice of PREVENTATIVE MEDICINE. http://lnkd.in/pDSXqm View in LinkedIn
linkedin post 2013-02-15 03:44:31
THE EUROPEAN LEAD FACTORY OF SHELVED DRUG CANDIDATES is an historic initiative. Previously bunkered, many of these molecules have been tested for safety in man. They were developed because they were potent biological modifiers. Opening the repurposing door to academia and industry is valuable. This is one of a number of initiatives that Big Pharma is taking to remedy a broken discovery model. Everyone wins. http://pipeline.corante.com/archives/2013/02/12/the_european_lead_factory.php View in LinkedIn